Immunogenicity and protective efficacy of RSV G central conserved domain vaccine with a prefusion nanoparticle

Respiratory syncytial virus (RSV) G glycoprotein has recently reemerged as a vaccine antigen due to its ability to elicit potent neutralizing antibodies and ameliorate disease in animal models. Here we designed three constructs to display the G central conserved domain (Gcc) focused on inducing broa...

Descripción completa

Detalles Bibliográficos
Autores principales: Rainho-Tomko, Jennifer N., Pavot, Vincent, Kishko, Michael, Swanson, Kurt, Edwards, Darin, Yoon, Heesik, Lanza, Lilibeth, Alamares-Sapuay, Judith, Osei-Bonsu, Robert, Mundle, Sophia T., Murison, Dave A., Gallichan, Scott, Delagrave, Simon, Wei, Chih-Jen, Zhang, Linong, Nabel, Gary J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244890/
https://www.ncbi.nlm.nih.gov/pubmed/35773301
http://dx.doi.org/10.1038/s41541-022-00487-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9244890/
https://www.ncbi.nlm.nih.gov/pubmed/35773301
http://dx.doi.org/10.1038/s41541-022-00487-9

Ejemplares similares